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Background: Whipple’s disease is a systemic infection that sometimes is associated with cardiac manifestations.
The diagnosis of Tropheryma whipplei endocarditis is still the result of chance because there are no diagnostic
criteria and clinical signs are often those of cardiac disease rather than infection.
Case presentation: Culture-negative endocarditis was suspected in a non-febrile 77-year-old French woman from
North France with a history of a graft replacement 4 years prior. Positron emission tomography revealed intense
fluorodeoxyglucose uptake around the metal ring of the aortic graft. The valve was replaced, and T. whipplei was
detected in a valve sample by molecular assays. Immunohistochemical staining of the valve for T. whipplei was also
positive.
Conclusion: The localization of infectious foci by positron emission tomography and systematically testing valve
specimens for T. whipplei are promising for diagnosing Whipple’s disease.
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Cardiovascular disease is the leading cause of death in
the United States and worldwide [1]. Blood culture-
negative endocarditis accounts for 2.5% to 31% of all
cases of endocarditis [2]. Blood culture-negative endo-
carditis is a severe and difficult-to-diagnose disease, but
our understanding of it has greatly improved over the
past 2 decades [2]. Tropheryma whipplei, the causative
agent of Whipple’s disease has been indicated as an
agent of blood culture-negative endocarditis [3]. T.
whipplei endocarditis differs from classic Whipple’s dis-
ease, which primarily affects the gastrointestinal system.
The bacterium can also cause localized chronic infec-
tions such as spondylodiscitis, meningoencephalitis, uve-
itis, and pneumonia. T. whipplei endocarditis is an
emerging clinical entity mostly observed in middle-aged
and older men with arthralgia [3]. The diagnosis of T.
whipplei endocarditis is based on molecular assays of
surgically obtained heart valves [3]. Positron emission
tomography (PET) is a promising tool for the identifica-
tion of infectious foci, especially in culture-negative* Correspondence: angelotasmanos@msn.com
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higher sensitivity than computed tomography (CT) for
the evaluation of the extent and localization of infections
[4]. We report one case of a culture-negative endocardi-
tis localized by PET and diagnosed as T. whipplei endo-
carditis by molecular assays and histology.
Case presentation
A non-febrile 77-year-old French woman from North
France was admitted to the hospital for faintness and
neurological deficit with right hemiplegia and aphasia.
The patient had a history of a graft replacement of her
aortic valve 4 years before. Laboratory values revealed
increased C-reactive protein and white blood cell count.
Liver enzyme levels were normal. Brain magnetic reson-
ance imaging (MRI) revealed two recent ischemic areas
and CT scanning showed linear hypodensity in the pos-
terior part of the spleen and two hypodense areas of the
cortex of the right kidney. Based on the numerous ische-
mic zones, a cardiac cause was suspected. Transesopha-
geal echocardiogram showed diffuse thickening of the
bioprosthesis; mobile, high-potential-embolic, bioprosth-
esis stenosis; and intra-prosthetic aortic insufficiency.
PET scan revealed intense fluorodeoxyglucose uptake
around the metal ring of the aortic graft (Figure 1). Thes is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Fluorodeoxyglucose uptake around the metal ring of the aortic graft revealed by PET scan.
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amoxicillin and clavulanic acid (12 g/day) and gentamy-
cin (120 mg 2 times per day) was started. Gram staining
and standard cultures of the valve and blood were all
negative. A valve sample was sent to our reference cen-
ter in Marseille. DNA was extracted from this sample
using a QIAamp tissue kit (Qiagen, Hilden, Germany)
according to the manufacturer’s recommendations.
Then, DNA extracts were tested by qPCR for the presence
of Tropheryma whipplei, Coxiella burnetti, Bartonella sp.,
Staphylococcus aureus, Enterococcus faecalis, Enterococcus
faecium, Mycoplasma pneumonia, Streptococcus oralis,
Streptococcus gallolyticus, Escherichia coli and fungi [5].
All assays were negative except those for T. whipplei. A
second qPCR assay targeting repeated sequences of T.
whipplei [6,7] confirmed the diagnosis. In addition, PCR
amplification and sequencing of the 16S rRNA gene [5]
was also positive for T. whipplei. Genotyping was per-
formed as previously described [8] and showed that
this T. whipplei was genotype 16. Immunohistochemi-
cal staining of the valve for T. whipplei was positive
(Figure 2) [9]. Culturing of the valve was negative. A
course of 200 mg oral doxycycline once per day with
200 mg hydroxychloroquine three times per day forFigure 2 T. whipplei-positive immunohistochemical staining of the va18 months was introduced. The diagnosis for this
patient was T. whipplei endocarditis in the context of a
bioprosthetic aortic valve.
Discussion
We report a case of T. whipplei endocarditis localized
using PET scanning. The diagnosis of Whipple’s disease
was then established by molecular assays and histology
on the valve bioprosthesis. Infective endocarditis is as-
sociated with poor prognosis despite improvements in
medical and surgical therapies [4]. Although the first
description of T. whipplei endocarditis was made ap-
proximately 15 years ago, diagnosing this disease re-
mains difficult because clinical signs are often those of
cardiac disease rather than infection [3,10]. The first
case was detected by chance when a broad-spectrum
PCR was systematically applied to heart valve speci-
mens [10]. PET scanning has been used to detect peri-
prosthetic valve abscesses even in cases in which
transesophageal echocardiography and transthoracic
echocardiography were normal or doubtful, particularly
in cases of prosthetic valve infections, in which results
of initial echocardiography are not useful in 30% of
cases [4]. The localization of infectious foci by PET hadlve sample.
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Whipple’s disease [11,12] and has been used to detect
periprosthetic valve abscesses even in cases in which
transesophageal echocardiography and transthoracic
echocardiography were normal or doubtful [4]. In our
case, PET scanning was especially valuable in the early
diagnosis of T. whipplei endocarditis because it identi-
fied uptake at the graft replacement of the aortic valve,
indicating an infection.
Blood culture-negative endocarditis accounts for
2.5%–31% of all cases of endocarditis. T. whipplei endo-
carditis is an emerging clinical entity mostly observed in
middle-aged and older men with arthralgia [3]. Indeed,
the disease occurs mainly in white men who are
~50 years of age with cardiac manifestations such as
heart failure, acute ischemic stroke, and peripheral arterial
embolism [3]. T. whipplei endocarditis is a frequent patho-
gen among cases of endocarditis, but its diagnosis is still
the result of chance because there are no diagnostic
criteria and clinical signs are often those of cardiac dis-
ease rather than infection [3,13]. In heart valves, T.
whipplei is surrounded by an inflammatory process and
inside the macrophages [3]. T. whipplei-infected heart
valves show the typical histologic features of infective
endocarditis: vegetations, inflammatory infiltrates, and
valvular destruction. The diagnosis of T. whipplei endocar-
ditis is based on molecular assays of surgically obtained
heart valves [3]. The performance of repeat PCR for T.
whipplei on blood specimens is a major criterion in the
Duke classification for endocarditis.
Genotyping revealed that the valve was infected by T.
whipplei genotype 16. T. whipplei genotyping has shown
high genetic diversity unrelated to pathogenicity [14]. T.
whipplei genotype 16 has been detected in the cerebro-
spinal fluid of a patient with neurological Whipple’s
disease in Germany and in the synovial fluid of a patient
with classic Whipple’s disease [8]. Moreover, it has been
detected in the gastric juice of a patient without clinical
manifestations from Switzerland [8]. In Europe, T. whip-
plei genotype 3 is the most common genotype and appears
to be epidemic and specific to France, Switzerland, and
Italy [8]. The second most common genotype in Europe is
the genotype 1, which is endemic and mainly observed in
central Europe.
Conclusions
We report a case that illustrates the usefulness of
18FDG-PET/CT for diagnosis of T. whipplei infectious
endocarditis in a patient with a graft replacement of the
aortic valve. The localization of infectious foci by PET
scanning and the systematic testing of valve specimens for
T. whipplei are promising, and these procedures can be
performed in patients of all ages by adjusting the dose of
18FDG to the weight of the patient. Thus, we believe thatT. whipplei should be considered in the diagnosis of
culture-negative endocarditis and that PET scanning
might be helpful in the diagnosis of T. whipplei infectious
endocarditis, although it will not replace clinical evalu-
ation, laboratory tests, and echocardiography.
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